What role does vitamin D play in psoriasis care, what percentage of patients are deficient, and how does supplementation compare with phototherapy?

The Psoriasis Strategy™ By Julissa Clay to treat your skin problem of psoriasis The Psoriasis Strategy can be the best option for you as it can help you in curing your skin problem without worsening or harming your skin condition. All the tips provided in this eBook can help you in treating your psoriasis permanently, regardless of the period you are suffering from it.

What role does vitamin D play in psoriasis care, what percentage of patients are deficient, and how does supplementation compare with phototherapy?

Vitamin D plays a critical role in psoriasis care by inhibiting the rapid growth of skin cells and modulating the underlying immune system dysfunction that drives the disease. A very high proportion of patients are deficient, with a large body of evidence showing that 60% to 90% of individuals with psoriasis have insufficient or deficient vitamin D levels. When comparing treatments, topical vitamin D supplementation (in the form of analogs) is a first-line therapy for mild-to-moderate psoriasis, while phototherapy is a more potent, second-line treatment for moderate-to-severe disease, with a key part of its mechanism being the production of vitamin D directly within the skin.

☀️ A Ray of Hope: The Central Role of Vitamin D in Psoriasis Care ☀️

Psoriasis is a chronic, immune-mediated inflammatory disease that manifests as thick, red, scaly patches on the skin. At its core, it is a condition of dysregulationskin cells that are growing too quickly and an immune system that is mistakenly attacking the body’s own tissues. In the complex landscape of psoriasis treatment, vitamin D has emerged not just as a supportive nutrient, but as a cornerstone of therapy. It plays a fundamental biological role in correcting the very cellular and immunological errors that define the disease. The link is further solidified by the extremely high prevalence of vitamin D deficiency found in this patient population. An examination of the therapeutic options reveals that vitamin D is delivered in two distinct ways: directly to the skin as a first-line topical supplement, and indirectly as a key mediator of the effects of phototherapy for more severe disease.

## a master regulator: the role of vitamin d in psoriasis care

The therapeutic power of vitamin D in psoriasis is rooted in its function as a potent hormone that regulates cell growth and the immune system. The active form of vitamin D, calcitriol, exerts its effects by binding to vitamin D receptors (VDR) found on numerous cells throughout the body, including the primary cells of the skin (keratinocytes) and key immune cells like T-lymphocytes.

Psoriasis is characterized by the hyperproliferation of keratinocytesthese skin cells are dividing and maturing at a rate that is up to ten times faster than normal, leading to the buildup of thick plaques. Vitamin D is a powerful inhibitor of this proliferation. When calcitriol binds to the VDR on a keratinocyte, it sends a signal that slows down the cell’s replication cycle. At the same time, it promotes normal cell differentiation, encouraging the immature skin cells to mature properly into the protective outer layer of the skin, rather than piling up into a psoriatic plaque.

Beyond its effects on the skin cells, vitamin D is a significant immunomodulator. Psoriasis is driven by a specific branch of the immune system, particularly T-helper cells (Th1 and Th17), which produce inflammatory signals (cytokines) that command the skin to over-proliferate. Vitamin D helps to rebalance the immune system by suppressing the activity of these pro-inflammatory T-cells and promoting the activity of more regulatory, anti-inflammatory immune cells. In essence, vitamin D works in two ways: it tells the skin cells to slow down their growth, and it tells the immune system to calm down its attack.

## a deficient population: the prevalence in patients

The strong biological link between vitamin D and psoriasis is mirrored by a striking clinical observation: a very high proportion of patients with psoriasis are deficient in vitamin D. Numerous observational studies and large-scale meta-analyses from around the world have consistently found that psoriasis patients have significantly lower blood levels of vitamin D compared to the general population.

The statistics are compelling. A comprehensive meta-analysis that pooled data from many individual studies concluded that a large majority of psoriasis patients have suboptimal vitamin D status. The reported prevalence varies between studies, but the data consistently show that between 60% and 90% of individuals with psoriasis are either vitamin D deficient or insufficient. Furthermore, many of these studies have found a direct correlation between vitamin D levels and the severity of the disease. Patients with lower vitamin D levels tend to have more severe psoriasis, as measured by clinical scoring systems like the Psoriasis Area and Severity Index (PASI). While it is not definitively proven whether the low vitamin D is a cause or a consequence of the disease, this strong association highlights the importance of assessing and correcting vitamin D status as part of a comprehensive psoriasis care plan.

## ⚖️ a comparative look: supplementation vs. phototherapy

The therapeutic application of vitamin D for psoriasis is delivered in several ways, and the comparison is not a simple matter of one versus the other, but of understanding which modality is best for which stage of the disease.

Vitamin D Supplementation, for psoriasis, primarily comes in the form of topical vitamin D analogs, such as calcipotriene (also known as calcipotriol) and calcitriol. These are synthetic, lab-made versions of active vitamin D that are formulated into creams, ointments, and solutions to be applied directly to the psoriatic plaques. Topical vitamin D analogs are a first-line, gold-standard treatment for mild to moderate plaque psoriasis. They are highly effective at slowing down skin cell growth and reducing the thickness and scaling of plaques. They have an excellent safety profile for long-term use and are often combined with topical corticosteroids for a more potent effect. The role of oral vitamin D supplementation, while crucial for correcting a systemic deficiency and supporting bone and overall health, is not considered a primary, standalone treatment for the skin disease itself. While some studies suggest it may have a modest beneficial effect, it is not powerful enough on its own to control moderate to severe psoriasis.

Phototherapy, or light therapy, is a second-line treatment reserved for patients with moderate to severe psoriasis that is too widespread or resistant to be effectively managed with topical agents alone. The most common and effective form is narrowband ultraviolet B (NB-UVB) phototherapy. This involves exposing the skin to a specific, therapeutic wavelength of light for a few minutes, several times a week. The mechanism of NB-UVB is complex, but its primary effect is localized immunosuppression in the skin, which calms the psoriatic inflammation.

The comparison between phototherapy and vitamin D is fascinating because they are deeply interconnected. A key part of how phototherapy works is by stimulating the production of vitamin D directly within the skin cells. The UVB radiation is the same stimulus that causes vitamin D production from sun exposure. This locally produced vitamin D then binds to the VDRs in the skin and exerts its potent anti-proliferative and immunomodulatory effects exactly where it is needed most. Therefore, phototherapy is not an alternative to vitamin D; it is a powerful method of endogenous, targeted vitamin D delivery.

In conclusion, the two treatments are not competitors but exist on a therapeutic ladder. For mild to moderate disease, a topical vitamin D analog is a safe and effective first-line choice. For more severe disease, phototherapy is a more powerful and appropriate option, and its profound therapeutic effect is mediated, in large part, by the very vitamin D that it produces within the patient’s own skin. Correcting a systemic vitamin D deficiency with oral supplements is a wise and necessary step for a patient’s overall health, but the direct treatment of the psoriasis itself relies on getting the vitamin D to the skin, either from a tube or from a light.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more